WADA statement regarding Maria Sharapova case

Press Release

8 June 2016 – WADA acknowledges the decision issued today by the International Tennis Federation’s (ITF) Independent Tribunal which found that Maria Sharapova committed an Anti-Doping Rule Violation (ADRV) for the use of banned substance Meldonium, and that, as a consequence, a period of ineligibility of two (2) years has been imposed, commencing on 26 January 2016.

As with all decisions made by Anti-Doping Organizations, WADA will review the decision, including its reasoning, and will subsequently decide whether or not to use its independent right of appeal to the Court of Arbitration for Sport (CAS).

Thursday, 09 June 2016

• Anti-Doping Anti-Doping Rule Violations (ADRV) Court of Arbitration for Sport (CAS) Governance International Tennis Federation (ITF) Regulation WADA Prohibited List World Anti-Doping Agency (WADA)